These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38576352)

  • 21. Antiidiotype (Ab2) vaccine therapy for cutaneous T-cell lymphoma.
    Chatterjee M; Mrozek E; Vaickus L; Oseroff A; Stoll H; Russell D; Kohler H; Foon KA
    Ann N Y Acad Sci; 1993 Aug; 690():376-7. PubMed ID: 8368761
    [No Abstract]   [Full Text] [Related]  

  • 22. Interferons for cutaneous T-cell lymphoma monotherapy or combination with PUVA.
    Roenigk HH; Kuzel T; Rosen S
    Australas J Dermatol; 1993; 34(1):13-5. PubMed ID: 8240181
    [No Abstract]   [Full Text] [Related]  

  • 23. Cutaneous T-cell lymphoma: a model for selective immunotherapy.
    Edelson RL
    Cancer J Sci Am; 1998; 4(2):62-71. PubMed ID: 9532405
    [No Abstract]   [Full Text] [Related]  

  • 24. Allogeneic Haematopoietic Stem Cell Transplantation for Patients with Cutaneous T-cell Lymphoma.
    Väkevä L; Niittyvuopio R; Leppä S; Heiskanen J; Lindström V; Ranki A; Volin L
    Acta Derm Venereol; 2016 Aug; 96(6):816-7. PubMed ID: 26864630
    [No Abstract]   [Full Text] [Related]  

  • 25. Cutaneous lymphomas management during COVID-19 pandemic.
    Vitiello P; Sica A; Ronchi A; Pastore F; Casale B; Argenziano G
    Ital J Dermatol Venerol; 2021 Apr; 156(2):248-249. PubMed ID: 33084270
    [No Abstract]   [Full Text] [Related]  

  • 26. [Local treatments of cutaneous T-cell lymphomas].
    Bachelez H
    Ann Dermatol Venereol; 2005 Sep; 132 Spec No 2():5S23-6. PubMed ID: 16385895
    [No Abstract]   [Full Text] [Related]  

  • 27. A case of poikiloderma vasculare atrophicans, a rare variant of cutaneous T-cell lymphoma, responding to extracorporeal photopheresis.
    Kreuter A; Hoffmamm K; Altmeyer P
    J Am Acad Dermatol; 2005 Apr; 52(4):706-8. PubMed ID: 15793532
    [No Abstract]   [Full Text] [Related]  

  • 28. British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018.
    Gilson D; Whittaker SJ; Child FJ; Scarisbrick JJ; Illidge TM; Parry EJ; Mohd Mustapa MF; Exton LS; Kanfer E; Rezvani K; Dearden CE; Morris SL
    Br J Dermatol; 2019 Mar; 180(3):496-526. PubMed ID: 30561020
    [No Abstract]   [Full Text] [Related]  

  • 29. Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma.
    Dippel E; Schrag H; Goerdt S; Orfanos CE
    Lancet; 1997 Jul; 350(9070):32-3. PubMed ID: 9217723
    [No Abstract]   [Full Text] [Related]  

  • 30. Middle-term evolution of patients with advanced cutaneous T-cell lymphoma treated with high-dose recombinant interleukin-2.
    Baccard M; Marolleau JP; Rybojad M
    Arch Dermatol; 1997 May; 133(5):656. PubMed ID: 9158425
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of cutaneous T-cell lymphoma: an update.
    Young JW
    J Am Osteopath Assoc; 1993 May; 93(5):591-8, 603. PubMed ID: 8314721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous malignancies: KA, CTCL, and KS.
    Vargo N
    Dermatol Nurs; 2006 Jun; 18(3):270, 277. PubMed ID: 16856684
    [No Abstract]   [Full Text] [Related]  

  • 33. Cutaneous T cell lymphomas.
    Bunn PA
    BMJ; 1994 Feb; 308(6928):551-2. PubMed ID: 8031362
    [No Abstract]   [Full Text] [Related]  

  • 34. Advances in the management of cutaneous T-cell lymphoma.
    Sinha AA; Heald P
    Dermatol Clin; 1998 Apr; 16(2):301-11. PubMed ID: 9589203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of maintenance phototherapy in cutaneous T-cell lymphoma.
    Pothiawala SZ; Baldwin BT; Cherpelis BS; Glass LF; Fenske NA
    J Drugs Dermatol; 2010 Jul; 9(7):800-3. PubMed ID: 20677536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Management of cutaneous lymphoma ].
    Beylot-Barry M; Battistella M
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 2):H13-8. PubMed ID: 21703465
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cutaneous lymphoma at the Dermatology Day conference, Paris 2010].
    Battistella M
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 2):H1-11. PubMed ID: 21703464
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic advances in cutaneous T-cell lymphoma.
    Akilov OE; Geskin L
    Skin Therapy Lett; 2011 Feb; 16(2):1-5. PubMed ID: 21591544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful stem cell transplantation in a patient with primary cutaneous aggressive cytotoxic epidermotropic CD8+ T-cell lymphoma.
    Wehkamp U; Glaeser D; Oschlies I; Hilgendorf I; Klapper W; Weichenthal M
    Br J Dermatol; 2015 Sep; 173(3):869-71. PubMed ID: 25816848
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferon alfa-induced interstitial pneumonitis in a patient with cutaneous T-cell lymphoma.
    Nouri K; Valor R; Rodriguez FM; Kerdel FA
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):269-70. PubMed ID: 8708036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.